Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CON NEC T trial of acetylcysteine prophylaxis and contrast media type in PCI patients at risk of contrast-induced nephropathy
2009-011175-70Phase 4Unknown
- Sponsor
- Liverpool Heart and Chest Hospital
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of acetylcysteine, iodixanol and ioversol in contrast-induced nephropathy (CIN) (4 arms), sponsored by Liverpool Heart and Chest Hospital. Primary endpoint: eGFR at 6 months. Status: unknown.
02
Drugs
acetylcysteineiodixanolioversol
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on 2009-011175-70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011175-70.